Pembroke Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.5M Sell
372,325
-140,543
-27% -$8.44M 2.81% 12
2025
Q4
$30.2M Buy
512,868
+135,891
+36% +$8.26M 3.12% 11
2025
Q3
$21M Buy
376,977
+37,189
+11% +$1.99M 2.08% 21
2025
Q2
$17.5M Buy
339,788
+87,913
+35% +$4.42M 2.11% 20
2025
Q1
$14.8M Sell
251,875
-8,167
-3% -$553K 2.15% 19
2024
Q4
$18.7M Sell
260,042
-54,658
-17% -$4.01M 2.34% 19
2024
Q3
$25.2M Sell
314,700
-3,056
-1% -$230K 3.21% 10
2024
Q2
$22.8M Buy
317,756
+34,497
+12% +$2.54M 3.06% 11
2024
Q1
$19.9M Sell
283,259
-82,258
-23% -$5.89M 2.35% 15
2023
Q4
$28.2M Sell
365,517
-94
-0% -$6.19K 3.5% 7
2023
Q3
$24.9M Buy
365,611
+26,020
+8% +$2.06M 3.4% 6
2023
Q2
$27.7M Buy
339,591
+34,586
+11% +$2.78M 2.99% 10
2023
Q1
$22.6M Sell
305,005
-18,971
-6% -$1.46M 2.47% 16
2022
Q4
$26.9M Buy
323,976
+25,776
+9% +$2.05M 2.87% 10
2022
Q3
$21.2M Sell
298,200
-5,016
-2% -$433K 2.35% 15
2022
Q2
$26.3M Sell
303,216
-1,784
-0.6% -$167K 2.72% 11
2022
Q1
$33M Buy
305,000
+7,548
+3% +$779K 2.76% 8
2021
Q4
$38.5M Sell
297,452
-4,872
-2% -$597K 2.82% 8
2021
Q3
$36.6M Buy
302,324
+1,748
+0.6% +$213K 2.76% 5
2021
Q2
$33.8M Sell
300,576
-2,704
-0.9% -$285K 2.65% 6
2021
Q1
$29M Buy
303,280
+51,712
+21% +$4.72M 2.41% 10
2020
Q4
$20M Buy
251,568
+8,548
+4% +$619K 1.68% 26
2020
Q3
$15.1M Buy
+243,020
New +$15.8M 1.64% 29

Other funds holding TECH

Pembroke Management's TECH Position: Q1 2026 in Review

Pembroke Management reduced its Bio-Techne (TECH) stake by 27% in Q1 2026, selling an estimated $8.44M and leaving 372,325 shares worth $19.5M. The position accounts for 2.81% of the portfolio, ranked #12.

Pembroke Management first reported a position in TECH in Q3 2020 and has held it in 23 quarters since. The position peaked at $38.5M in Q4 2021. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Pembroke Management held 372,325 shares of Bio-Techne worth $19.5M as of Q1 2026.
  • Pembroke Management sold 140,543 Bio-Techne shares in Q1 2026, an estimated $8.44M.
  • Bio-Techne made up 2.81% of Pembroke Management's portfolio in Q1 2026, its #12 holding.
  • Pembroke Management first reported a position in Bio-Techne in Q3 2020 and has held it in 23 quarters since.
  • Pembroke Management's Bio-Techne position peaked at $38.5M in Q4 2021.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Pembroke Management's 13F filing for Q1 2026, filed 14 May 2026.